ArticleEClinicalMedicine2024

TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial.

Lene Baeksgaard Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.